Thai drug system’s challenges and responses to the global agenda of UHC

Meeting Organizer

Health Systems Research Institute (HSRI), Thailand

Ministry of Public health, Food and Drug Administration, Pharmacy Council, Thai Industrial Pharmacist Association and Thai Drug Watch

Contact Person : NoppakunThammatacharee,

29 January 2020
09:00 - 17:30 hrs.
Venue : World Ballroom A, FL. 23

Open to All Participants


Health expenditure on drugs in Thailand has been increasing substantially. It was estimated that drug costs accounted for more than 40% of the total health expenditure. This is due to the change in population structure, complicated health conditions and expensive technology. Additionally, arrangements in the drug system also affect the performance to control drug costs as well as the country’s ability to maintain good health for the Thai population. These include management of the overall drug supply chain, the inputs such as human resource, financing provided to the drug system and, most importantly, policy and regulations on pharmaceutical products at national and international levels. Access to affordable essential medicine on a sustainable basis is stated in the Sustainable Development Goal target 3.8 achieve universal health coverage (UHC). This can be achieved by a number of ways such as transparent pricing and procurement, increased regulatory capacity and streamlined administrative procedures, support to local manufacturing process and improvement in rational use of medicines.


1) Share and discuss current situations about key activities, outputs/outcomes, and progress on drug system by public health practitioners, academicians, policy makers, and other interest groups 2) Provide evidence for policies, regulations and systems for the drug system in Thailand 3) Address common and major gaps to further identify areas in need of greater attention 4) Advocate for effective responses to the challenges of the Thai drug system